Music BroadMBL) has filed draft prospectus with capital market regulator SEBI to bring its IPO. MBL is a fully-owned subsidiary of Jagran Prakashan which publishes leading Hindi daily Dainik Jagran among other newspapers.
Capital market regulator SEBI has cleared the IPO application of New Delhi-based Matrix Cellular International Services, taking the total number of approvals this year to 26. The international SIM card provider filed its draft red herring prospectus (DRHP) with SEBI through IIFL Holding on 23 June. The regulator issued its observations in this regard on 26 August. SEBI’s observation amounts to regulatory clearance to bring out the IPO.
Telecom sector is not doing well for some time and no positivist in next few months moreover Matrix Cellular is pathetic in terms of services and charges.. I personally know at least 10 friends who used their services in abroad.. There is a big difference in what they say and what they charge... People feel cheated after getting their bills... Not a good company among customers and top of it telecom sector... Not at all thinking to apply whenever it comes.
860.2. Eagleye| Link| Bookmark|
December 17, 2016 3:20:40 PM
IPO Guru (6600+ Posts, 21900+ Likes)
Mr.IPO Sir,
Which era are you living in?
MATRIX CELLULAR (INTERNATIONAL) SERVICES LIMITED filed its DRHP with SEBI last year .. on June 22, 2015
you may access the same here ... http://www.sebi.gov.in/cms/sebi_data/attachdocs/1435043879942.pdf
SEBI approved the IPO ... but later the Company decided to withdraw the same ... as they had no buyers
860.3. Eagleye| Link| Bookmark|
December 17, 2016 3:22:49 PM
IPO Guru (6600+ Posts, 21900+ Likes)
Mr.IPO Sir,
Please refrain from sharing unverified information ... use this forum for serious and authenticate data sharing only _/\_
By considering 31 GMP, we are near to EAGLEYE''s target of 470 in 4 week of listing. I will not be surprised if it breaks 470 and run towards 500. By seeing the price behavior of other Pharma stocks and people''s moods who loves Pharma stocks, it will be a darling of them.
Pharma stocks are no longer darling for investors. CNX Pharma made a high of 14000 points in April 2015 and today pharma index is down 25% from its high whereas nifty is down only 10% from its high. Pharma Stocks are under-performers and will continue to under-perform going forward